Mereo BioPharma Group Plc (MREO)

0.25 -0.02 (-8.16%) USD  |  NASDAQ  |  Sep 04, 16:00
0.25 0.00 (0.00%) After-Hours: 20:00
More

Mereo BioPharma Group SG&A Expense (TTM) : 19.44M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 19.44M
March 31, 2026 19.77M
December 31, 2025 23.06M
September 30, 2025 25.26M
June 30, 2025 25.52M
Date Value
March 31, 2025 27.84M
December 31, 2024 26.44M
September 30, 2024 20.05M
June 30, 2024 13.78M
March 31, 2024 5.903M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc 6.375M
NuCana Plc 7.064M
BioNTech SE 833.57M
Silence Therapeutics Plc 21.27M
Autolus Therapeutics Plc 152.92M